Internal Medicine Alert – November 30, 2010

November 30, 2010

• Lifetime Follow-up Care after Childhood Cancer

  Lifetime surveillance is required after successful treatment of childhood cancers, since up to 75% of survivors develop serious complications and other late effects.

  Read more

• Is It a Coincidence that Death Rhymes with Breath?

  Pulmonary function can help predict cardiovascular death risk in individuals in the intermediate-risk group of Framingham Risk Scores.

  Read more

• Should Everyone Be on Fish Oils?

  Marine n-3 PUFAs act as pleiotropic agents on the cardiovascular system with a diverse range of effects most of which are beneficial for patients with known cardiovascular disease and possibly, they may even have beneficial effects with regard to the primary prevention of cardiovascular disease.

  Read more

• Dabigatran Etexilate mesylate Capsules (Pradaxa®)

  Dabigatran is indicated for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.

  Read more

• Clinical Briefs By Louis Kuritzky, MD

  Since the publication of the allhat trial, clinicians have progressively relied upon diuretic-based regimens to manage hypertension (HTN).

  Read more